---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-144274"
form_type: "8-K"
ticker: "IMA"
cik: "0001835579"
company_name: "ImageneBio, Inc."
filed_at: "2023-05-15T23:59:59+00:00"
generated_at: "2026-06-15T01:33:48.627462+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Ikena raises ~$40M in equity offering; Q1 cash $137.8M; runway to 2026

## Summary
- Underwritten offering of 6.11M shares at $6.55/share for gross proceeds of ~$40M; closing expected May 17, 2023.
- Cash, equivalents and marketable securities $137.8M at March 31, 2023; offering proceeds extend cash runway into 2026.
- Q1 collaboration revenue $5.3M (up from $3.4M YoY); R&D expense $15.6M; G&A $5.3M.
- IK-930 initial monotherapy data expected 4Q 2023; IK-595 IND filing planned 2H 2023; IK-175 Fast Track designation in March.

## SEC filing metadata
- accession: 0001193125-23-144274
- form_type: 8-K
- ticker: IMA
- cik: 0001835579
- company_name: ImageneBio, Inc.
- filed_at: 2023-05-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835579/000119312523144274/0001193125-23-144274-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835579/000119312523144274/d504516d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-144274
- JSON: https://secwatch.observer/filing/0001193125-23-144274.json
- Plain text: https://secwatch.observer/filing/0001193125-23-144274.txt

## Key facts
- Material Agreements
  ImageneBio, Inc. entered into Underwriting Agreement with Cowen and Company, LLC and William Blair & Company, L.L.C., as representatives of the underwriters valued at approximately $40,020,500 million (effective 2023-05-15).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Cowen and Company, LLC and William Blair & Company, L.L.C., as representatives of the underwriters
  - Value: approximately $40,020,500 million
  - Effective: 2023-05-15
  source text: On May 15, 2023, Ikena Oncology, Inc., a Delaware corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Cowen and Company, LLC and William Blair & Company, L.L.C., as representatives of the underwriters listed on Schedule A thereto (collectively, the “Underwriters”), relating to an underwritten registered offering (the “Offering”) of 6,110,000 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”), at a price of $6.550 per share, less underwriting discounts and commissions.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835579/000119312523144274/0001193125-23-144274-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.